KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Cash: 2017-2025

Historic Change in Cash for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$18.5 million.

  • Twist Bioscience's Change in Cash fell 43.20% to -$18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.7 million, marking a year-over-year increase of 27.34%. This contributed to the annual value of -$43.7 million for FY2025, which is 27.34% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Cash of -$18.5 million as of Q3 2025, which was down 104.38% from -$9.0 million recorded in Q2 2025.
  • Twist Bioscience's Change in Cash's 5-year high stood at $216.0 million during Q1 2022, with a 5-year trough of -$274.2 million in Q4 2021.
  • For the 3-year period, Twist Bioscience's Change in Cash averaged around -$12.2 million, with its median value being -$11.1 million (2025).
  • Per our database at Business Quant, Twist Bioscience's Change in Cash skyrocketed by 327.39% in 2022 and then crashed by 1,396.73% in 2024.
  • Over the past 5 years, Twist Bioscience's Change in Cash (Quarterly) stood at -$274.2 million in 2021, then skyrocketed by 77.69% to -$61.2 million in 2022, then soared by 67.03% to -$20.2 million in 2023, then skyrocketed by 74.84% to -$5.1 million in 2024, then crashed by 43.20% to -$18.5 million in 2025.
  • Its Change in Cash was -$18.5 million in Q3 2025, compared to -$9.0 million in Q2 2025 and -$11.1 million in Q1 2025.